{"id":"https://openalex.org/W2074056751","doi":"https://doi.org/10.1016/j.neuropharm.2009.06.005","title":"The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems","display_name":"The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems","alternate_titles":[],"publication_year":2009,"publication_date":"2009-06-19","ids":{"openalex":"https://openalex.org/W2074056751","doi":"https://doi.org/10.1016/j.neuropharm.2009.06.005","mag":"2074056751","pmid":"https://pubmed.ncbi.nlm.nih.gov/19539634"},"language":"en","primary_location":{"id":"doi:10.1016/j.neuropharm.2009.06.005","doi":"https://doi.org/10.1016/j.neuropharm.2009.06.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.neuropharm.2009.06.005","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2074056751"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017334559","display_name":"Katarzyna Stachowicz","orcid":"https://orcid.org/0000-0003-4330-7128","observed_orcids":["https://orcid.org/0000-0003-4330-7128"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K. Stachowicz","raw_affiliation_strings":["Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland","Institute of Pharmacology, Polish Academy of Sciences, Sme\u0327tna 12, 31-343-Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Sme\u0327tna 12, 31-343-Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061982723","display_name":"Aleksandra K\u0142odzi\u0144ska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. K\u0142odzi\u0144ska","raw_affiliation_strings":["Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, 31-343 Krakow, Poland","Institute of Pharmacology, Polish Academy of Sciences, Sme\u0327tna 12, 31-343-Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, 31-343 Krakow, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Sme\u0327tna 12, 31-343-Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052898318","display_name":"Agnieszka Pa\u0142ucha-Poniewiera","orcid":"https://orcid.org/0000-0001-9890-6844","observed_orcids":["https://orcid.org/0000-0001-9890-6844"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Palucha-Poniewiera","raw_affiliation_strings":["Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, 31-343 Krakow, Poland","Institute of Pharmacology, Polish Academy of Sciences, Sme\u0327tna 12, 31-343-Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, 31-343 Krakow, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Sme\u0327tna 12, 31-343-Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051852907","display_name":"St\u00e9phan Schann","orcid":"https://orcid.org/0000-0001-7471-491X","observed_orcids":["https://orcid.org/0000-0001-7471-491X"]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Schann","raw_affiliation_strings":["Domain Therapeutics, SA, BIOPARC, Boulevard S\u00e9bastien Brant, 67400 Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Domain Therapeutics, SA, BIOPARC, Boulevard S\u00e9bastien Brant, 67400 Illkirch, France","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042174239","display_name":"Pascal Neuville","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Neuville","raw_affiliation_strings":["Domain Therapeutics, SA, BIOPARC, Boulevard S\u00e9bastien Brant, 67400 Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Domain Therapeutics, SA, BIOPARC, Boulevard S\u00e9bastien Brant, 67400 Illkirch, France","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082517862","display_name":"Andrzej Pilc","orcid":"https://orcid.org/0000-0002-4045-0597","observed_orcids":["https://orcid.org/0000-0002-4045-0597"]},"institutions":[{"id":"https://openalex.org/I126596746","display_name":"Jagiellonian University","ror":"https://ror.org/03bqmcz70","country_code":"PL","type":"education","lineage":["https://openalex.org/I126596746"]},{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"A. Pilc","raw_affiliation_strings":["Collegium Medicum, Jagiellonian University, Krak\u00f3w, Poland","Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, 31-343 Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Collegium Medicum, Jagiellonian University, Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I126596746"]},{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, 31-343 Krakow, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5082517862"],"corresponding_institution_ids":["https://openalex.org/I126596746","https://openalex.org/I4210120768","https://openalex.org/I99542240"],"apc_list":{"value":4300,"currency":"USD","value_usd":4300},"apc_paid":null,"fwci":1.9345,"has_fulltext":false,"cited_by_count":46,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.8351092,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"57","issue":"3","first_page":"227","last_page":"234"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.06750000268220901,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.04769999906420708,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anxiolytic-like-effects","display_name":"anxiolytic-like effects","score":0.9259999990463257},{"id":"https://openalex.org/keywords/antidepressant-like-effects","display_name":"antidepressant-like effects","score":0.9950000047683716},{"id":"https://openalex.org/keywords/serotonergic-system","display_name":"serotonergic system","score":0.8610000014305115},{"id":"https://openalex.org/keywords/gabaergic-system","display_name":"GABAergic system","score":0.9819999933242798},{"id":"https://openalex.org/keywords/5-ht1a-receptor","display_name":"5-HT1A receptor","score":0.875},{"id":"https://openalex.org/keywords/5-ht2a-c-receptor","display_name":"5-HT2A/C receptor","score":0.8809999823570251},{"id":"https://openalex.org/keywords/flumazenil","display_name":"flumazenil","score":0.7950000166893005},{"id":"https://openalex.org/keywords/way-100635","display_name":"WAY-100635","score":0.9039999842643738},{"id":"https://openalex.org/keywords/stress-induced-hyperthermia","display_name":"stress-induced hyperthermia","score":0.9390000104904175},{"id":"https://openalex.org/keywords/elevated-plus-maze","display_name":"elevated plus maze","score":0.8330000042915344},{"id":"https://openalex.org/keywords/tail-suspension-test","display_name":"tail suspension test","score":0.7329999804496765},{"id":"https://openalex.org/keywords/forced-swim-test","display_name":"forced swim test","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C2777450907","wikidata":"https://www.wikidata.org/wiki/Q3937260","display_name":"Ritanserin","level":5,"score":0.8502289056777954},{"id":"https://openalex.org/C2778409475","wikidata":"https://www.wikidata.org/wiki/Q421920","display_name":"Flumazenil","level":4,"score":0.7602232694625854},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.7361496686935425},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.727668821811676},{"id":"https://openalex.org/C2781001258","wikidata":"https://www.wikidata.org/wiki/Q7676084","display_name":"Tail suspension test","level":5,"score":0.6714459657669067},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.603714644908905},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5976026058197021},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5684740543365479},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5610151886940002},{"id":"https://openalex.org/C136569192","wikidata":"https://www.wikidata.org/wiki/Q4880745","display_name":"Behavioural despair test","level":4,"score":0.5492265224456787},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.5251731276512146},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.4866269528865814},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.47574517130851746},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43751299381256104},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4176117181777954},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.36884674429893494},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3319751024246216},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3079774081707001},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2578820586204529},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.053510844707489014}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003517","descriptor_name":"Cyclopentanes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003517","descriptor_name":"Cyclopentanes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005442","descriptor_name":"Flumazenil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007274","descriptor_name":"Injections, Intraperitoneal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013315","descriptor_name":"Stress, Psychological","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D013315","descriptor_name":"Stress, Psychological","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014233","descriptor_name":"Tricarboxylic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014233","descriptor_name":"Tricarboxylic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016713","descriptor_name":"Ritanserin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058787","descriptor_name":"GABA-A Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058829","descriptor_name":"Serotonin 5-HT1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058830","descriptor_name":"Serotonin 5-HT2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.neuropharm.2009.06.005","doi":"https://doi.org/10.1016/j.neuropharm.2009.06.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.neuropharm.2009.06.005","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:19539634","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19539634","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":67,"referenced_works":["https://openalex.org/W30417382","https://openalex.org/W89939163","https://openalex.org/W658377763","https://openalex.org/W1549849604","https://openalex.org/W1564717701","https://openalex.org/W1595843790","https://openalex.org/W1785379738","https://openalex.org/W1894780092","https://openalex.org/W1970034042","https://openalex.org/W1976564830","https://openalex.org/W1980354246","https://openalex.org/W1980457050","https://openalex.org/W1982543967","https://openalex.org/W1983160636","https://openalex.org/W1985423204","https://openalex.org/W1989458523","https://openalex.org/W1990407514","https://openalex.org/W1990988842","https://openalex.org/W1991125327","https://openalex.org/W1991891142","https://openalex.org/W1992090445","https://openalex.org/W1996275603","https://openalex.org/W2001311316","https://openalex.org/W2005594217","https://openalex.org/W2007417518","https://openalex.org/W2009617328","https://openalex.org/W2009823135","https://openalex.org/W2012568585","https://openalex.org/W2015778209","https://openalex.org/W2020184819","https://openalex.org/W2024942419","https://openalex.org/W2028288155","https://openalex.org/W2038551427","https://openalex.org/W2038644671","https://openalex.org/W2041197933","https://openalex.org/W2043166209","https://openalex.org/W2043440058","https://openalex.org/W2044866903","https://openalex.org/W2046928397","https://openalex.org/W2058092335","https://openalex.org/W2060589548","https://openalex.org/W2061054421","https://openalex.org/W2061070984","https://openalex.org/W2062816282","https://openalex.org/W2066564897","https://openalex.org/W2067795636","https://openalex.org/W2075672970","https://openalex.org/W2078612746","https://openalex.org/W2082369948","https://openalex.org/W2086614619","https://openalex.org/W2087097962","https://openalex.org/W2092204227","https://openalex.org/W2092602308","https://openalex.org/W2106042714","https://openalex.org/W2134289201","https://openalex.org/W2153853866","https://openalex.org/W2170146962","https://openalex.org/W2197078876","https://openalex.org/W2277185635","https://openalex.org/W2336104751","https://openalex.org/W2400530249","https://openalex.org/W2405041541","https://openalex.org/W2414030574","https://openalex.org/W2414331423","https://openalex.org/W2420936415","https://openalex.org/W2951764089","https://openalex.org/W3142909662"],"related_works":["https://openalex.org/W4244185182","https://openalex.org/W2414331423","https://openalex.org/W2007417518","https://openalex.org/W2029007040","https://openalex.org/W2034827137","https://openalex.org/W2405041541","https://openalex.org/W2044866903","https://openalex.org/W1974520644","https://openalex.org/W16382191"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2074056751","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
